Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
KIT 1件: KIT 💬Acute myeloid leukemia
|
Imatinib mesylate Imatinib mesylate 💬Acute myeloid leukemia
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬1. Acute myeloid leukemia
|
|||||||||||||||||||||||||||||||||||||||||||||||
2 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
KIT 1件: KIT 💬Acute myeloid leukemia
|
Imatinib Imatinib 💬Acute myeloid leukemia
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬1. Acute myeloid leukemia
|
|||||||||||||||||||||||||||||||||||||||||||||||
3 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
VEGFA 1件: VEGFA 💬AGE-RAGE signaling pathway in diabetic complications
|
Bevacizumab Bevacizumab 💬AGE-RAGE signaling pathway in diabetic complications
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬3. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||
4 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 75 diseases |
ABL1 1件: ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Axon guidance
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬4. Axon guidance
|
|||||||||||||||||||||||||||||||||||||||||||||||
5 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 75 diseases |
ABL1 1件: ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Axon guidance
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬4. Axon guidance
|
|||||||||||||||||||||||||||||||||||||||||||||||
6 | Bladder cancer 💬 11 genes, 27 drugs (DrugBank) and 33 diseases |
VEGFA 1件: VEGFA 💬Bladder cancer
|
Bevacizumab Bevacizumab 💬Bladder cancer
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬6. Bladder cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
7 | Breast cancer 💬 22 genes, 63 drugs (DrugBank) and 80 diseases |
KIT 1件: KIT 💬Breast cancer
|
Imatinib mesylate Imatinib mesylate 💬Breast cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬7. Breast cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
8 | Breast cancer 💬 22 genes, 63 drugs (DrugBank) and 80 diseases |
KIT 1件: KIT 💬Breast cancer
|
Imatinib Imatinib 💬Breast cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬7. Breast cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
9 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
PDGFRA 1件: PDGFRA 💬Calcium signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬Calcium signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬9. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
10 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
PDGFRA 1件: PDGFRA 💬Calcium signaling pathway
|
Imatinib Imatinib 💬Calcium signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬9. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
11 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
VEGFA 1件: VEGFA 💬Calcium signaling pathway
|
Bevacizumab Bevacizumab 💬Calcium signaling pathway
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬11. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
12 | Cell cycle 💬 11 genes, 12 drugs (DrugBank) and 25 diseases |
ABL1 1件: ABL1 💬Cell cycle
|
Imatinib mesylate Imatinib mesylate 💬Cell cycle
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬12. Cell cycle
|
|||||||||||||||||||||||||||||||||||||||||||||||
13 | Cell cycle 💬 11 genes, 12 drugs (DrugBank) and 25 diseases |
ABL1 1件: ABL1 💬Cell cycle
|
Imatinib Imatinib 💬Cell cycle
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬12. Cell cycle
|
|||||||||||||||||||||||||||||||||||||||||||||||
14 | Central carbon metabolism in cancer 💬 19 genes, 37 drugs (DrugBank) and 65 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Central carbon metabolism in cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬14. Central carbon metabolism in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
15 | Central carbon metabolism in cancer 💬 19 genes, 37 drugs (DrugBank) and 65 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Central carbon metabolism in cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬14. Central carbon metabolism in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
16 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
ABL1 1件: ABL1 💬Chemical carcinogenesis - reactive oxygen species
|
Imatinib mesylate Imatinib mesylate 💬Chemical carcinogenesis - reactive oxygen species
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬16. Chemical carcinogenesis - reactive oxygen species
|
|||||||||||||||||||||||||||||||||||||||||||||||
17 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
ABL1 1件: ABL1 💬Chemical carcinogenesis - reactive oxygen species
|
Imatinib Imatinib 💬Chemical carcinogenesis - reactive oxygen species
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬16. Chemical carcinogenesis - reactive oxygen species
|
|||||||||||||||||||||||||||||||||||||||||||||||
18 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
VEGFA 1件: VEGFA 💬Chemical carcinogenesis - reactive oxygen species
|
Bevacizumab Bevacizumab 💬Chemical carcinogenesis - reactive oxygen species
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬18. Chemical carcinogenesis - reactive oxygen species
|
|||||||||||||||||||||||||||||||||||||||||||||||
19 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
VEGFA 1件: VEGFA 💬Chemical carcinogenesis - receptor activation
|
Bevacizumab Bevacizumab 💬Chemical carcinogenesis - receptor activation
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬19. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||
20 | Choline metabolism in cancer 💬 11 genes, 30 drugs (DrugBank) and 61 diseases |
PDGFRA 1件: PDGFRA 💬Choline metabolism in cancer
|
Imatinib mesylate Imatinib mesylate 💬Choline metabolism in cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬20. Choline metabolism in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
21 | Choline metabolism in cancer 💬 11 genes, 30 drugs (DrugBank) and 61 diseases |
PDGFRA 1件: PDGFRA 💬Choline metabolism in cancer
|
Imatinib Imatinib 💬Choline metabolism in cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬20. Choline metabolism in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
22 | Chronic myeloid leukemia 💬 17 genes, 23 drugs (DrugBank) and 36 diseases |
ABL1 1件: ABL1 💬Chronic myeloid leukemia
|
Imatinib mesylate Imatinib mesylate 💬Chronic myeloid leukemia
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬22. Chronic myeloid leukemia
|
|||||||||||||||||||||||||||||||||||||||||||||||
23 | Chronic myeloid leukemia 💬 17 genes, 23 drugs (DrugBank) and 36 diseases |
ABL1 1件: ABL1 💬Chronic myeloid leukemia
|
Imatinib Imatinib 💬Chronic myeloid leukemia
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬22. Chronic myeloid leukemia
|
|||||||||||||||||||||||||||||||||||||||||||||||
24 | Endocytosis 💬 22 genes, 37 drugs (DrugBank) and 54 diseases |
PDGFRA 1件: PDGFRA 💬Endocytosis
|
Imatinib mesylate Imatinib mesylate 💬Endocytosis
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬24. Endocytosis
|
|||||||||||||||||||||||||||||||||||||||||||||||
25 | Endocytosis 💬 22 genes, 37 drugs (DrugBank) and 54 diseases |
PDGFRA 1件: PDGFRA 💬Endocytosis
|
Imatinib Imatinib 💬Endocytosis
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬24. Endocytosis
|
|||||||||||||||||||||||||||||||||||||||||||||||
26 | ErbB signaling pathway 💬 14 genes, 28 drugs (DrugBank) and 62 diseases |
ABL1 1件: ABL1 💬ErbB signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬ErbB signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬26. ErbB signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
27 | ErbB signaling pathway 💬 14 genes, 28 drugs (DrugBank) and 62 diseases |
ABL1 1件: ABL1 💬ErbB signaling pathway
|
Imatinib Imatinib 💬ErbB signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬26. ErbB signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
28 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
VEGFA 1件: VEGFA 💬Fluid shear stress and atherosclerosis
|
Bevacizumab Bevacizumab 💬Fluid shear stress and atherosclerosis
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬28. Fluid shear stress and atherosclerosis
|
|||||||||||||||||||||||||||||||||||||||||||||||
29 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
PDGFRA 1件: PDGFRA 💬Focal adhesion
|
Imatinib mesylate Imatinib mesylate 💬Focal adhesion
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬29. Focal adhesion
|
|||||||||||||||||||||||||||||||||||||||||||||||
30 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
PDGFRA 1件: PDGFRA 💬Focal adhesion
|
Imatinib Imatinib 💬Focal adhesion
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬29. Focal adhesion
|
|||||||||||||||||||||||||||||||||||||||||||||||
31 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
VEGFA 1件: VEGFA 💬Focal adhesion
|
Bevacizumab Bevacizumab 💬Focal adhesion
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬31. Focal adhesion
|
|||||||||||||||||||||||||||||||||||||||||||||||
32 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
PDGFRA 1件: PDGFRA 💬Gap junction
|
Imatinib mesylate Imatinib mesylate 💬Gap junction
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬32. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||
33 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
PDGFRA 1件: PDGFRA 💬Gap junction
|
Imatinib Imatinib 💬Gap junction
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬32. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||
34 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 64 diseases |
PDGFRA 1件: PDGFRA 💬Glioma
|
Imatinib mesylate Imatinib mesylate 💬Glioma
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬34. Glioma
|
|||||||||||||||||||||||||||||||||||||||||||||||
35 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 64 diseases |
PDGFRA 1件: PDGFRA 💬Glioma
|
Imatinib Imatinib 💬Glioma
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬34. Glioma
|
|||||||||||||||||||||||||||||||||||||||||||||||
36 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
KIT 1件: KIT 💬Hematopoietic cell lineage
|
Imatinib mesylate Imatinib mesylate 💬Hematopoietic cell lineage
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬36. Hematopoietic cell lineage
|
|||||||||||||||||||||||||||||||||||||||||||||||
37 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
KIT 1件: KIT 💬Hematopoietic cell lineage
|
Imatinib Imatinib 💬Hematopoietic cell lineage
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬36. Hematopoietic cell lineage
|
|||||||||||||||||||||||||||||||||||||||||||||||
38 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
VEGFA 1件: VEGFA 💬HIF-1 signaling pathway
|
Bevacizumab Bevacizumab 💬HIF-1 signaling pathway
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬38. HIF-1 signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
39 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PDGFRA 1件: PDGFRA 💬Human cytomegalovirus infection
|
Imatinib mesylate Imatinib mesylate 💬Human cytomegalovirus infection
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬39. Human cytomegalovirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||
40 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PDGFRA 1件: PDGFRA 💬Human cytomegalovirus infection
|
Imatinib Imatinib 💬Human cytomegalovirus infection
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬39. Human cytomegalovirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||
41 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
VEGFA 1件: VEGFA 💬Human cytomegalovirus infection
|
Bevacizumab Bevacizumab 💬Human cytomegalovirus infection
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬41. Human cytomegalovirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||
42 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
VEGFA 1件: VEGFA 💬Human papillomavirus infection
|
Bevacizumab Bevacizumab 💬Human papillomavirus infection
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬42. Human papillomavirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||
43 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
PDGFRA 1件: PDGFRA 💬JAK-STAT signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬JAK-STAT signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬43. JAK-STAT signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
44 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
PDGFRA 1件: PDGFRA 💬JAK-STAT signaling pathway
|
Imatinib Imatinib 💬JAK-STAT signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬43. JAK-STAT signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
45 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
VEGFA 1件: VEGFA 💬Kaposi sarcoma-associated herpesvirus infection
|
Bevacizumab Bevacizumab 💬Kaposi sarcoma-associated herpesvirus infection
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬45. Kaposi sarcoma-associated herpesvirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||
46 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬MAPK signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬46. MAPK signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
47 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib Imatinib 💬MAPK signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬46. MAPK signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
48 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
VEGFA 1件: VEGFA 💬MAPK signaling pathway
|
Bevacizumab Bevacizumab 💬MAPK signaling pathway
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬48. MAPK signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
49 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
KIT 1件: KIT 💬Melanogenesis
|
Imatinib mesylate Imatinib mesylate 💬Melanogenesis
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬49. Melanogenesis
|
|||||||||||||||||||||||||||||||||||||||||||||||
50 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
KIT 1件: KIT 💬Melanogenesis
|
Imatinib Imatinib 💬Melanogenesis
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬49. Melanogenesis
|
|||||||||||||||||||||||||||||||||||||||||||||||
51 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 42 diseases |
PDGFRA 1件: PDGFRA 💬Melanoma
|
Imatinib mesylate Imatinib mesylate 💬Melanoma
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬51. Melanoma
|
|||||||||||||||||||||||||||||||||||||||||||||||
52 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 42 diseases |
PDGFRA 1件: PDGFRA 💬Melanoma
|
Imatinib Imatinib 💬Melanoma
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬51. Melanoma
|
|||||||||||||||||||||||||||||||||||||||||||||||
53 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
ABL1 2件: ABL1, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬MicroRNAs in cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬53. MicroRNAs in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
54 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
ABL1 2件: ABL1, PDGFRA 💬
|
Imatinib Imatinib 💬MicroRNAs in cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬53. MicroRNAs in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
55 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
VEGFA 1件: VEGFA 💬MicroRNAs in cancer
|
Bevacizumab Bevacizumab 💬MicroRNAs in cancer
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬55. MicroRNAs in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
56 | Neurotrophin signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 37 diseases |
ABL1 1件: ABL1 💬Neurotrophin signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬Neurotrophin signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬56. Neurotrophin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
57 | Neurotrophin signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 37 diseases |
ABL1 1件: ABL1 💬Neurotrophin signaling pathway
|
Imatinib Imatinib 💬Neurotrophin signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬56. Neurotrophin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
58 | Pancreatic cancer 💬 19 genes, 40 drugs (DrugBank) and 84 diseases |
VEGFA 1件: VEGFA 💬Pancreatic cancer
|
Bevacizumab Bevacizumab 💬Pancreatic cancer
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬58. Pancreatic cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
59 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
ABL1 1件: ABL1 💬Pathogenic Escherichia coli infection
|
Imatinib mesylate Imatinib mesylate 💬Pathogenic Escherichia coli infection
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬59. Pathogenic Escherichia coli infection
|
|||||||||||||||||||||||||||||||||||||||||||||||
60 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
ABL1 1件: ABL1 💬Pathogenic Escherichia coli infection
|
Imatinib Imatinib 💬Pathogenic Escherichia coli infection
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬59. Pathogenic Escherichia coli infection
|
|||||||||||||||||||||||||||||||||||||||||||||||
61 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
ABL1 3件: ABL1, KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Pathways in cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬61. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
62 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
ABL1 3件: ABL1, KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Pathways in cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬61. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
63 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
VEGFA 1件: VEGFA 💬Pathways in cancer
|
Bevacizumab Bevacizumab 💬Pathways in cancer
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬63. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
64 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Phospholipase D signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬64. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
65 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Phospholipase D signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬64. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
66 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬PI3K-Akt signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬66. PI3K-Akt signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
67 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib Imatinib 💬PI3K-Akt signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬66. PI3K-Akt signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
68 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
VEGFA 1件: VEGFA 💬PI3K-Akt signaling pathway
|
Bevacizumab Bevacizumab 💬PI3K-Akt signaling pathway
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬68. PI3K-Akt signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
69 | Prostate cancer 💬 24 genes, 57 drugs (DrugBank) and 89 diseases |
PDGFRA 1件: PDGFRA 💬Prostate cancer
|
Imatinib mesylate Imatinib mesylate 💬Prostate cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬69. Prostate cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
70 | Prostate cancer 💬 24 genes, 57 drugs (DrugBank) and 89 diseases |
PDGFRA 1件: PDGFRA 💬Prostate cancer
|
Imatinib Imatinib 💬Prostate cancer
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬69. Prostate cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
71 | Proteoglycans in cancer 💬 33 genes, 73 drugs (DrugBank) and 103 diseases |
VEGFA 1件: VEGFA 💬Proteoglycans in cancer
|
Bevacizumab Bevacizumab 💬Proteoglycans in cancer
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬71. Proteoglycans in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||
72 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Rap1 signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬72. Rap1 signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
73 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
KIT 2件: KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Rap1 signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬72. Rap1 signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
74 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
VEGFA 1件: VEGFA 💬Rap1 signaling pathway
|
Bevacizumab Bevacizumab 💬Rap1 signaling pathway
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬74. Rap1 signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
75 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
ABL1 3件: ABL1, KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Ras signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬75. Ras signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
76 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
ABL1 3件: ABL1, KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Ras signaling pathway
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬75. Ras signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
77 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
VEGFA 1件: VEGFA 💬Ras signaling pathway
|
Bevacizumab Bevacizumab 💬Ras signaling pathway
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬77. Ras signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
78 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
PDGFRA 1件: PDGFRA 💬Regulation of actin cytoskeleton
|
Imatinib mesylate Imatinib mesylate 💬Regulation of actin cytoskeleton
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬78. Regulation of actin cytoskeleton
|
|||||||||||||||||||||||||||||||||||||||||||||||
79 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
PDGFRA 1件: PDGFRA 💬Regulation of actin cytoskeleton
|
Imatinib Imatinib 💬Regulation of actin cytoskeleton
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬78. Regulation of actin cytoskeleton
|
|||||||||||||||||||||||||||||||||||||||||||||||
80 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
VEGFA 1件: VEGFA 💬Relaxin signaling pathway
|
Bevacizumab Bevacizumab 💬Relaxin signaling pathway
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬80. Relaxin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
81 | Renal cell carcinoma 💬 12 genes, 16 drugs (DrugBank) and 26 diseases |
VEGFA 1件: VEGFA 💬Renal cell carcinoma
|
Bevacizumab Bevacizumab 💬Renal cell carcinoma
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬81. Renal cell carcinoma
|
|||||||||||||||||||||||||||||||||||||||||||||||
82 | Rheumatoid arthritis 💬 38 genes, 59 drugs (DrugBank) and 87 diseases |
VEGFA 1件: VEGFA 💬Rheumatoid arthritis
|
Bevacizumab Bevacizumab 💬Rheumatoid arthritis
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬82. Rheumatoid arthritis
|
|||||||||||||||||||||||||||||||||||||||||||||||
83 | VEGF signaling pathway 💬 23 genes, 56 drugs (DrugBank) and 94 diseases |
VEGFA 1件: VEGFA 💬VEGF signaling pathway
|
Bevacizumab Bevacizumab 💬VEGF signaling pathway
| Bevacizumab | 013 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬83. VEGF signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
84 | Viral myocarditis 💬 34 genes, 27 drugs (DrugBank) and 52 diseases |
ABL1 1件: ABL1 💬Viral myocarditis
|
Imatinib mesylate Imatinib mesylate 💬Viral myocarditis
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬84. Viral myocarditis
|
|||||||||||||||||||||||||||||||||||||||||||||||
85 | Viral myocarditis 💬 34 genes, 27 drugs (DrugBank) and 52 diseases |
ABL1 1件: ABL1 💬Viral myocarditis
|
Imatinib Imatinib 💬Viral myocarditis
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬84. Viral myocarditis
|
Acute myeloid leukemia
18 genes, 37 drugs (DrugBank) and 71 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 55 drugs (DrugBank) and 96 diseases
Axon guidance
22 genes, 26 drugs (DrugBank) and 75 diseases
Bladder cancer
11 genes, 27 drugs (DrugBank) and 33 diseases
Breast cancer
22 genes, 63 drugs (DrugBank) and 80 diseases
Calcium signaling pathway
86 genes, 214 drugs (DrugBank) and 143 diseases
Cell cycle
11 genes, 12 drugs (DrugBank) and 25 diseases
Central carbon metabolism in cancer
19 genes, 37 drugs (DrugBank) and 65 diseases
Chemical carcinogenesis - reactive oxygen species
25 genes, 39 drugs (DrugBank) and 51 diseases
Chemical carcinogenesis - receptor activation
39 genes, 135 drugs (DrugBank) and 134 diseases
Choline metabolism in cancer
11 genes, 30 drugs (DrugBank) and 61 diseases
Chronic myeloid leukemia
17 genes, 23 drugs (DrugBank) and 36 diseases
Endocytosis
22 genes, 37 drugs (DrugBank) and 54 diseases
ErbB signaling pathway
14 genes, 28 drugs (DrugBank) and 62 diseases
Fluid shear stress and atherosclerosis
34 genes, 59 drugs (DrugBank) and 93 diseases
Focal adhesion
31 genes, 51 drugs (DrugBank) and 52 diseases
Gap junction
26 genes, 97 drugs (DrugBank) and 82 diseases
Glioma
15 genes, 34 drugs (DrugBank) and 64 diseases
Hematopoietic cell lineage
53 genes, 95 drugs (DrugBank) and 101 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Human papillomavirus infection
51 genes, 106 drugs (DrugBank) and 115 diseases
JAK-STAT signaling pathway
61 genes, 113 drugs (DrugBank) and 123 diseases
Kaposi sarcoma-associated herpesvirus infection
60 genes, 94 drugs (DrugBank) and 118 diseases
MAPK signaling pathway
65 genes, 98 drugs (DrugBank) and 109 diseases
Melanogenesis
7 genes, 19 drugs (DrugBank) and 34 diseases
Melanoma
17 genes, 34 drugs (DrugBank) and 42 diseases
MicroRNAs in cancer
33 genes, 75 drugs (DrugBank) and 90 diseases
Neurotrophin signaling pathway
22 genes, 29 drugs (DrugBank) and 37 diseases
Pancreatic cancer
19 genes, 40 drugs (DrugBank) and 84 diseases
Pathogenic Escherichia coli infection
28 genes, 43 drugs (DrugBank) and 78 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
Phospholipase D signaling pathway
23 genes, 59 drugs (DrugBank) and 82 diseases
PI3K-Akt signaling pathway
85 genes, 142 drugs (DrugBank) and 131 diseases
Prostate cancer
24 genes, 57 drugs (DrugBank) and 89 diseases
Proteoglycans in cancer
33 genes, 73 drugs (DrugBank) and 103 diseases
Rap1 signaling pathway
45 genes, 113 drugs (DrugBank) and 98 diseases
Ras signaling pathway
37 genes, 64 drugs (DrugBank) and 70 diseases
Regulation of actin cytoskeleton
35 genes, 82 drugs (DrugBank) and 81 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 51 diseases
Renal cell carcinoma
12 genes, 16 drugs (DrugBank) and 26 diseases
Rheumatoid arthritis
38 genes, 59 drugs (DrugBank) and 87 diseases
VEGF signaling pathway
23 genes, 56 drugs (DrugBank) and 94 diseases
Viral myocarditis
34 genes, 27 drugs (DrugBank) and 52 diseases